Ozospas 20 mg Injection 2 ml
₹90*
MRP ₹100
10% off
₹85*
MRP ₹100
15% CB
₹15 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Ozospas 20 mg Injection 2 ml belongs to a group of medicines called anti-spasmodic agents used to treat smooth muscle spasms of the biliary tract, urinary tract, and gastrointestinal tract. It is also used to treat dysmenorrhea (painful periods) and severe spastic pain during labour.
Ozospas 20 mg Injection 2 ml contains 'Drotaverine', which works by relieving contractions associated with smooth muscles of the gastrointestinal tract, gall bladder, and urinary tract. Thus, it helps in relieving pain.
In some cases, Ozospas 20 mg Injection 2 ml may cause side effects such as nausea, headache, dizziness, constipation, and vertigo (spinning sensation). Most of these side effects do not require medical attention and resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Inform your doctor if you are pregnant or planning pregnancy before taking Ozospas 20 mg Injection 2 ml. Ozospas 20 mg Injection 2 ml is not recommended during breastfeeding. Ozospas 20 mg Injection 2 ml may cause dizziness, so drive only if you are alert. Keep your doctor informed about your health condition and medicines to rule out any side effects.
Ozospas 20 mg Injection 2 ml is an anti-spasmodic agent that is used to treat smooth muscle spasms of the biliary tract (gall bladder), urinary tract, and gastrointestinal tract (gastric/duodenal ulcer disease, spastic conditions of cardia and pylorus of stomach, irritable bowel syndrome, spastic constipation, flatulence, stomach inflammation, bowel inflammation). It is also prescribed for dysmenorrhea (painful periods) and severe spastic pain during labour. Ozospas 20 mg Injection 2 ml can also be used in uncomplicated labour during the cervical dilation phase to shorten the dilation and overall labour duration.
Do not take Ozospas 20 mg Injection 2 ml if you are allergic to any components. Inform your doctor if you have low blood pressure, porphyria (blood disorder), heart problems, or liver or kidney problems. Consult your doctor if you are pregnant or planning pregnancy. Ozospas 20 mg Injection 2 ml is not recommended during breastfeeding and in children. Ozospas 20 mg Injection 2 ml may cause dizziness, so drive only if you are alert. Let your doctor know if you are taking prescription/non-prescription medicines, including herbal products and supplements.
Drug-Drug Interactions: Ozospas 20 mg Injection 2 ml may interact with an anti-Parkinson agent (levodopa).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Inform your doctor if you have porphyria, low blood pressure, or severe heart, kidney or liver problems.
Smooth muscle spasms: Smooth muscle spasm is the sudden involuntary muscle contractions, which can be painful and uncomfortable. When the nerve impulses that control the muscle movements are damaged or interrupted, it could lead to muscle spasms. Symptoms include pain and cramps.
Alcohol
Caution
It is not known if alcohol interacts with Ozospas 20 mg Injection 2 ml. Please consult your doctor.
Pregnancy
Caution
Inform your doctor if you are pregnant or planning pregnancy before receiving Ozospas 20 mg Injection 2 ml. Your doctor will prescribe this medicine only if the benefits outweigh the risks.
Breast Feeding
Unsafe
It is not recommended to use Ozospas 20 mg Injection 2 ml while breastfeeding.
Driving
Caution
Ozospas 20 mg Injection 2 ml may cause dizziness. Do not drive or operate machinery after taking this medicine unless you are alert.
Liver
Caution
Caution is advised for patients with hepatic impairment. Please inform your doctor if you have liver problems before taking Ozospas 20 mg Injection 2 ml.
Kidney
Caution
Caution is advised for patients with renal impairment. Please inform your doctor if you have kidney problems before taking Ozospas 20 mg Injection 2 ml.
Children
Unsafe
Ozospas 20 mg Injection 2 ml is not recommended for use in children.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes